Measure Summaries
Australian Council on Healthcare Standards- Cardiovascular disease: percentage of inpatients undergoing coronary artery bypass grafts (CABGs) within 24 hours of percutaneous transluminal coronary angioplasty (PCTA) (with or without stenting) in the same admission, during the 6 month time period. This updates a previously published measure summary.
- Cardiovascular disease: percentage of patients discharged with a diagnosis of congestive heart failure (CHF) and atrial fibrillation (AF) who have no contraindication to the use of warfarin, who are prescribed warfarin, during the 6 month time period. This updates a previously published measure summary.
- Cardiovascular disease: percentage of patients discharged with a diagnosis of congestive heart failure (CHF) who have no contraindications to the use of an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor antagonist (A2RA) who are prescribed an ACEI or A2RA, during the 6 month time period. This updates a previously published measure summary.
- Cardiovascular disease: percentage of patients discharged with a diagnosis of congestive heart failure (CHF) who have no contraindications to the use of beta-blockers and who are prescribed beta-blocker therapy, during the 6 month time period. This updates a previously published measure summary.
- Cardiovascular disease: percentage of patients discharged with any diagnosis of congestive heart failure (CHF) who are referred for chronic disease management service that includes physical rehabilitation, during the 6 month time period. This updates a previously published measure summary.
No hay comentarios:
Publicar un comentario